Ekso Bionics to Present at the Groundbreak 2017 Construction Conference
March 27 2017 - 8:00AM
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton
company, today announced that Russ Angold, the company’s co-founder
and chief technology officer, will be a presenter at the ProCore
Groundbreak 2017 construction technology conference being held in
Austin, Texas on March 29-31, 2017.
During the ProCore annual conference, which attracts roughly
2,000 attendees, Ekso Bionics will demonstrate the EksoZeroG, a
lightweight assistive device that has been designed to bear the
load of heavy tools and enhance both safety and productivity for
workers at construction sites. A preview and hands-on
demonstration of additional new exoskeleton technology to aid in
overhead work will also be provided by Ekso Bionics.
“We are excited to demonstrate our technology at Groundbreak and
to generate awareness of our innovative construction technology,
which makes work sites safer and workers more productive,” said
Angold. “We are optimistic that conference attendees will leave the
conference wanting to integrate EksoZeroG technology on
their own jobsites.”
Angold’s brother, Ryan Angold, who himself suffered a spinal
cord injury, will discuss firsthand how to overcome life’s
challenges and will co-present.
Presentation: “Techno-geekery: Construction turns
sci-worthy”Thursday, March 30th, 2:45- 3:35pm, Mainstage
“I am so pleased with the progress we have made in advancing our
technologies for the industrial market and am excited to showcase
the EksoZeroG at Groundbreak 2017,” said Thomas Looby, president
and chief executive officer of Ekso Bionics. “Leveraging our
extensive IP, we are making advances that we believe will change
lives around the world, in both the medical and industrial
arenas.”
Ekso Bionics will also take part in the following upcoming
industrial trade shows:
- The Rise of the Machines Conference- April 6th, Chicago
- RIMS Annual Conference & Exhibition- April 23rd- 26th,
Philadelphia
- COLLISION Tech Conference- May 2nd-4th, New Orleans
- The International Rental Exposition- May 2nd-4th,
Amsterdam
To learn more, visit www.eksobionics.com.
About Ekso Bionics®Ekso Bionics is a leading
developer of exoskeleton solutions that amplify human potential by
supporting or enhancing strength, endurance and mobility across
medical, industrial and defense applications. Founded in 2005, the
company continues to build upon its unparalleled expertise to
design some of the most cutting-edge, innovative wearable robots
available on the market. Ekso Bionics is the only exoskeleton
company to offer technologies that range from helping those with
paralysis to stand up and walk, to enhancing human capabilities on
job sites across the globe, to providing research for the
advancement of R&D projects intended to benefit U.S. defense
capabilities. The company is headquartered in the Bay Area and is
listed on the Nasdaq Capital Market under the symbol EKSO. For more
information, visit: www.eksobionics.com.
Forward-Looking StatementsAny statements
contained in this press release that do not describe historical
facts may constitute forward-looking statements. Forward-looking
statements may include, without limitation, statements regarding
(i) the plans and objectives of management for future operations,
including plans or objectives relating to the design, development
and commercialization of human exoskeletons, (ii) estimates or
projection of financial results, financial condition, capital
expenditures, capital structure or other financial items, (iii) the
Company's future financial performance and (iv) the assumptions
underlying or relating to any statement described in points (i),
(ii) or (iii) above. Such forward-looking statements are not meant
to predict or guarantee actual results, performance, events or
circumstances and may not be realized because they are based upon
the Company's current projections, plans, objectives, beliefs,
expectations, estimates and assumptions and are subject to a number
of risks and uncertainties and other influences, many of which the
Company has no control over. Actual results and the timing of
certain events and circumstances may differ materially from those
described by the forward-looking statements as a result of these
risks and uncertainties. Factors that may influence or contribute
to the inaccuracy of the forward-looking statements or cause actual
results to differ materially from expected or desired results may
include, without limitation, the Company's inability to obtain
adequate financing to fund the Company's operations and necessary
to develop or enhance our technology, the significant length of
time and resources associated with the development of the Company's
products, the Company's failure to achieve broad market acceptance
of the Company's products, the failure of our sales and marketing
organization or partners to market our products effectively,
adverse results in future clinical studies of the Company's medical
device products, the failure to obtain or maintain patent
protection for the Company's technology, failure to obtain or
maintain regulatory approval to market the Company's medical
devices, lack of product diversification, existing or increased
competition, and the Company's failure to implement the Company's
business plans or strategies. These and other factors are
identified and described in more detail in the Company's filings
with the SEC. To learn more about Ekso Bionics please visit us at
www.eksobionics.com. The Company does not undertake to update these
forward-looking statements.
Ekso Bionics Media Contact:
Carrie Yamond
917-371-2320
cyamond@lazarpartners.com
Ekso Bionics Investor Contact:
Debbie Kaster
415-937-5403
investors@eksobionics.com
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Apr 2023 to Apr 2024